CONCLUSIONS: ADHD medication dispensing increased steeply in Norway during 2020-2022, especially among females and young adults. The pattern suggests a marked shift in ADHD pharmacological treatment, and the shift is not mirrored by comparable increases in dispensing of other psychotropic drug groups or in recorded public outpatient activity.
